Carbidopa and levodopa and Spinal disorder - a phase IV clinical study of FDA data

Summary:

Spinal disorder is reported as a side effect among people who take Carbidopa and levodopa (carbidopa; levodopa), especially for people who are female, 50-59 old, also take Fosamax, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Spinal disorder when taking Carbidopa and levodopa. It is created by eHealthMe based on reports of 5,664 people who have side effects when taking Carbidopa and levodopa from the FDA, and is updated regularly.

What is Carbidopa and levodopa?

Carbidopa and levodopa has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 6,152 Carbidopa and levodopa users. Check the latest studies of Carbidopa and levodopa.

What is Spinal disorder?

Spinal disorder (disease of spine a back bone) is found to be associated with 903 drugs and 801 conditions by eHealthMe. Check the latest studies of Spinal disorder.

On Aug, 12, 2026

5,664 people reported to have side effects when taking Carbidopa and levodopa.
Among them, 11 people (0.19%) have Spinal disorder.

Could Carbidopa and levodopa cause Spinal disorder?

Among these 11 people:

What is the gender of people who have Spinal disorder when taking Carbidopa and levodopa? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Spinal disorder when taking Carbidopa and levodopa? *

What are other drugs people take besides Carbidopa and levodopa? *

What are other side effects people have besides Spinal disorder? *

Pharyngitis (inflammation of the pharynx, causing a sore throat): 8 people, 72.73%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 63.64%
Pseudarthrosis (bones that do not heal after fracture): 7 people, 63.64%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 7 people, 63.64%
Stress And Anxiety: 7 people, 63.64%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 7 people, 63.64%
Spinal Osteoarthritis (joint cartilage loss in spine): 7 people, 63.64%
Colitis (inflammation of colon): 7 people, 63.64%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 63.64%
Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 7 people, 63.64%

What are the existing conditions these people have? *

High Blood Cholesterol: 7 people, 63.64%
Multiple Myeloma (cancer of the plasma cells): 3 people, 27.27%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Carbidopa and levodopa and have Spinal disorder?

- Check whether Spinal disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carbidopa and levodopa:

Carbidopa and levodopa (6,152 reports)

Spinal disorder treatments and more:

Spinal disorder (13,673 reports)

Browse all side effects of Carbidopa and levodopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Spinal disorder:

Spinal disorder (903 drugs)

Browse all the conditions that are associated with Spinal disorder:

Spinal disorder (801 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carbidopa; levodopa (the active ingredients of Carbidopa and levodopa) and Carbidopa and levodopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.